Angiotensin-(1-9) reduces cardiovascular and renal inflammation in experimental renin-independent hypertension

Biochem Pharmacol. 2018 Oct:156:357-370. doi: 10.1016/j.bcp.2018.08.045. Epub 2018 Sep 1.

Abstract

Hypertension-induced cardiovascular and renal damage can be mediated by activation of the renin-angiotensin-aldosterone system. There are different factors beyond renin-angiotensin-aldosterone system involved in hypertension and renal damage. Inflammation has emerged as an important mediator of hypertension and cardiovascular and kidney damage. Angiotensin-(1-9), a peptide of the renin-angiotensin system, counter-regulates both the physiological and pathological actions of angiotensin II. Recent data has shown that angiotensin-(1-9) protects the heart and blood vessels from adverse cardiovascular remodeling in experimental models of hypertension and/or heart failure and reduces cardiac fibrosis in stroke-prone, spontaneously hypertensive rats. These effects are mediated by the angiotensin II type 2 receptor (AT2R). However, it remains unknown whether angiotensin-(1-9) also has an anti-inflammatory effect. In the present study, we investigate whether angiotensin-(1-9) reduces inflammation and fibrosis in the heart, arteries, and kidney in a DOCA-salt hypertensive model and explore the mechanisms underlying the amelioration of end-organ damage. DOCA-salt hypertensive rats received: a) vehicle, b) angiotensin-(1-9), c) PD123319 (AT2R blocker), d) angiotensin-(1-9) plus A779 (a Mas receptor blocker) or e) angiotensin-(1-9) plus PD123319, and sham rats were used as a control. Our results showed that angiotensin-(1-9) decreased hypertension and increased vasodilation in DOCA-salt hypertensive rats. These actions were partially inhibited by PD123319. Moreover, angiotensin-(1-9) decreased diuresis, fibrosis, and inflammation. These beneficial effects were not mediated by Mas or AT2R blockers. We concluded that angiotensin-(1-9) protects against volume overload-induced hypertensive cardiovascular and kidney damage by decreasing inflammation in the heart, aortic wall, and kidney, through mechanisms independent of the Mas or AT2R.

Keywords: AT2 receptor; Angiotensin-(1-9); Fibrosis; Hypertension; Inflammation; Renin-angiotensin system.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / genetics
  • Actins / metabolism
  • Angiotensins / pharmacology*
  • Animals
  • Aorta / cytology
  • Aorta / drug effects
  • Aorta / pathology
  • Desoxycorticosterone / toxicity
  • Hypertension / chemically induced*
  • Hypertension / drug therapy
  • Inflammation / chemically induced*
  • Inflammation / drug therapy
  • Kidney Diseases / chemically induced*
  • Kidney Diseases / drug therapy
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Renin / metabolism*

Substances

  • Actins
  • Angiotensins
  • Desoxycorticosterone
  • Renin